ctrl K

Watchlist Price Alert

Landos Biopharma Inc. (LABP)

NASDAQ: LABP · Real-Time Price · USD

22.93

0.13 (0.57%)

At close: May 23, 2024, 8:00 PM

Landos Biopharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	18M	n/a	n/a	n/a
Cost of Revenue	n/a	577K	196K	137K	103K	n/a
Gross Profit	n/a	-577K	17.8M	-137K	-103K	n/a
Operating Income	-22.73M	-40.56M	-38.82M	-30.68M	-13.29M	-7.94M
Interest Income	n/a	n/a	412K	455K	n/a	n/a
Pretax Income	-21.93M	-39.28M	-38.42M	-30.14M	-13.47M	-6.04M
Net Income	-21.93M	-37.99M	-38.23M	-30.14M	-13.93M	-6.04M
Selling & General & Admin	10.73M	14.88M	15.25M	5.34M	1.48M	1.14M
Research & Development	12M	25.68M	41.56M	25.34M	11.81M	6.8M
Other Expenses	n/a	1.28M	394K	n/a	160K	2M
Operating Expenses	22.73M	40.56M	56.82M	30.68M	13.29M	7.94M
Interest Expense	n/a	n/a	n/a	n/a	304K	4K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	22.73M	40.56M	56.82M	30.68M	13.29M	7.94M
Income Tax Expense	n/a	-1.28M	-196K	n/a	464K	1.9M
Shares Outstanding (Basic)	6.28M	4.03M	4.03M	4.01M	4.01M	2.31M
Shares Outstanding (Diluted)	6.28M	4.03M	4.03M	4.01M	4.01M	2.31M
EPS (Basic)	-3.5	-9.44	-9.5	-7.51	-3.47	-2.62
EPS (Diluted)	-3.5	-9.44	-9.5	-7.51	-3.47	-2.62
EBITDA	-22.73M	-40.56M	-38.82M	-30.08M	-13.03M	-5.85M
EBIT	n/a	-39.85M	n/a	n/a	-13.16M	-6.04M
Depreciation & Amortization	44K	577K	196K	592K	263K	80K